Garden State Investment Advisory Services’s BridgeBio Pharma BBIO Stock Holding History

Garden State Investment Advisory Services’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$824K	Hold	11,065	–	–	0.15%	125
2026 Q1	$822K	Sell	11,065 -17	-0.2%	-$1.23K	0.18%	105
2025 Q4	$848K	Sell	11,082 -6	-0.1%	-$394	0.19%	103
2025 Q3	$576K	Hold	11,088	–	–	0.13%	133
2025 Q2	$479K	Sell	11,088 -280	-2%	-$10.2K	0.12%	154
2025 Q1	$393K	Hold	11,368	–	–	0.13%	148
2024 Q4	$312K	Sell	11,368 -220	-2%	-$5.68K	0.09%	175
2024 Q3	$295K	Hold	11,588	–	–	0.09%	175
2024 Q2	$294K	Sell	11,588 -100	-0.9%	-$2.73K	0.1%	167
2024 Q1	$360K	Sell	11,688 -140	-1%	-$4.76K	0.13%	142
2023 Q4	$477K	Buy	+11,828	New	+$355K	0.19%	108

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Garden State Investment Advisory Services's BBIO Position: Q2 2026 in Review

Garden State Investment Advisory Services held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 11,065 shares worth $824K. The position accounts for 0.15% of the portfolio, ranked #125.

Garden State Investment Advisory Services first reported a position in BBIO in Q4 2023 and has held it in 11 quarters since. The position peaked at $848K in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Garden State Investment Advisory Services held 11,065 shares of BridgeBio Pharma worth $824K as of Q2 2026.
Garden State Investment Advisory Services left its BridgeBio Pharma share count unchanged in Q2 2026.
BridgeBio Pharma made up 0.15% of Garden State Investment Advisory Services's portfolio in Q2 2026, its #125 holding.
Garden State Investment Advisory Services first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 11 quarters since.
Garden State Investment Advisory Services's BridgeBio Pharma position peaked at $848K in Q4 2025.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Garden State Investment Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.